Back

Discussant review - REBOOT-CNIC, BETAMI-DANBLOCK, CAPITAL-RCT

30 August 2025 (11:30 - 11:40)
Organised by: Logo
Congress Presentation Part of: HOT LINE 3 Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
REBOOT-CNIC: betablockers after infarction with LVEF greater than 40%
Professor B. Ibanez (Madrid, ES)
Slides Video
Presentation thumbnail
THE BETAMI-DANBLOCK TRIAL: RANDOMIZED DISCONTINUATION OF BETA-BLOCKERS AFTER MYOCARDIAL INFARCTION
Professor D. Atar (Oslo, NO)
Slides Video
Presentation thumbnail
REBOOT/BETAMI/DANBLOCK/CAPITAL-RCT: Beta-Blockers after MI with Mildly Reduced EF (an IPD meta-analysis)
Doctor F. Rossello (Palma de Mallorca, ES)
Slides Video
Presentation thumbnail
Panel discussion - REBOOT-CNIC, BETAMI-DANBLOCK, CAPITAL-RCT
Video
Presentation thumbnail
REFINE ICD: Efficacy of ICD therapy in higher risk post-MI patients with better-preserved LV function
Professor D. Exner (Calgary, CA)
Slides Video

Access the full session

Session thumbnail
HOT LINE 3
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Betablockers post-acute myocardial infarction
20 March 2026
thumbnail
Congress Session
The year in review: top trials in coronary interventions impacting guidelines and patient care
1 September 2024
thumbnail
Congress Presentation
Panel discussion - ABYSS
30 August 2024
thumbnail
Congress Presentation
Highlights from Day 1 at ESC Congress 2024: part 1
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources